CROMA PhilArt Eye 1x2 ml – Polynucleotide Biostimulator for Periocular Rejuvenation
 
CROMA PhilArt Eye 1x2 ml is a regenerative injectable treatment developed by CROMA-Pharma GmbH (Austria), formulated with high-purity PN-HPT™ polynucleotides for the delicate periocular area.
This advanced biostimulator improves skin quality, hydration, and elasticity, while visibly reducing dark circles, fine lines, and signs of fatigue.
Unlike hyaluronic acid fillers, PhilArt Eye works by stimulating cellular renewal and tissue regeneration, not by adding volume—making it perfect for patients seeking natural, radiant, and refreshed eyes.
 
Product Overview
PhilArt Eye is part of the Croma PhilArt regenerative line, designed for the periocular zone where skin is thinner and more prone to dryness and wrinkles.
It rejuvenates the under-eye area through biological stimulation, enhancing microcirculation and promoting collagen and elastin production for smoother, firmer, and more luminous skin.
 
Technology & Composition
Technology: PN-HPT™ (Polynucleotides Highly Purified Technology) — long-chain, highly purified DNA fragments that enhance dermal repair and hydration.
Composition:
• Polynucleotides (high purity) – stimulate fibroblast activity and improve skin regeneration.
• Buffer solution – maintains isotonicity and physiological pH.
• No hyaluronic acid or cross-linking agents.
Packaging (Content):
• 1 sterile vial of 2 ml
• Instruction leaflet and professional labeling
• Single-patient use only
 
Indications & Treatment Areas
Under-eye hollows and tired appearance
Dark circles and periorbital pigmentation
Fine lines and loss of elasticity around the eyes
Dehydrated or dull periocular skin
 
Clinical Benefits
Stimulates fibroblasts to improve collagen and elastin synthesis
Reduces dark circles and signs of fatigue
Enhances hydration and elasticity in the periocular skin
Improves microcirculation and tissue oxygenation
Non-volumizing and non-swelling — ideal for delicate skin around the eyes
 
Treatment Protocol
Sessions: 3–4 sessions spaced 2–3 weeks apart
Maintenance: every 6 months depending on skin condition
Application: microinjections into the lower eyelid and periocular area using mesotherapy or micropapule technique
Duration of results: visible improvements usually from the second session, lasting 6–9 months, depending on patient age and lifestyle
 
Manufacturer & Regulatory Information
Manufactured by CROMA-Pharma GmbH (Austria).
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745.
ISO 13485 certified manufacturer.
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union.
 
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety and patient care.